Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Urea SCHEMBL4916163 | 0.97 | GPR84 (0.36) | TSHRCAMK2APSMB8PSMB5GPR84 | |
| Ethylene Glycol SCHEMBL6129445 | 0.95 | TSHR (0.40) | TSHRCAMK2ASLC22A6PSMB8PSMB5 | |
| Ethylene Glycol SCHEMBL28342229 | 0.91 | GPR84 (0.42) | TSHRCAMK2ASLC22A6PSMB8PSMB5 | |
| Ethylene Glycol SCHEMBL28881509 | 0.91 | GPR84 (0.42) | TSHRCAMK2ASLC22A6PSMB8PSMB5 | |
| Urea SCHEMBL4909809 | 0.91 | PSMB8 (0.34) | PSMB8PSMB5 | |
| SCHEMBL34382 | 0.91 | TSHR (0.44) | TSHRCAMK2ASLC22A6PSMB8PSMB5 | |
| Ethylene Glycol SCHEMBL6523939 | 0.89 | PSMB8 (0.34) | TSHRPSMB8PSMB5KMT2A | |
| Urethane SCHEMBL4904899 | 0.88 | ALOX15 (0.38) | TSHRPSMB8PSMB5MEN1GAA | |
| SCHEMBL290460 | 0.87 | LMNA (0.41) | TSHRSLC22A6GPR84FFAR1FFAR4 | |
| SCHEMBL26665749 | 0.86 | TSHR (0.38) | TSHRSLC22A6PSMB8PSMB5MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | claimed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | claimed |
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | disclosed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | KRT18, CUTA, KRTCAP2 | TSHR 3358/4885CAMK2A 3964/4885SLC22A6 1716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.